FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to oncology, and concerns myelodysplastic syndrome treatment. For this purpose 4-pyridylmethylphthalazine derivative PTK787 is introduced in therapeutically effective amount.
EFFECT: method delays progression of the disease, including in the conventional chemotherapy resistant patients.
1 ex, 9 cl
Authors
Dates
2009-04-27—Published
2003-09-23—Filed